Visualitza VHIO - Articles científics per autor "Felip Font, Enriqueta"
Ara mostrant els elements 1-20 d 48
-
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Lazar, Vladimir; Zhang, Baolin; Magidi, Shai; Raymond, Eric; Ducreux, M.; Felip Font, Enriqueta; Tabernero Caturla, Josep; Le Tourneau, Christophe (SAGE Publications, 2023) -
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Callejo Perez, Ana; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin; Bar, Jair (Wiley, 2022-07) -
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
Goss, Glenwood D.; Syrigos, Konstantinos; Lee, Ki Hyeong; Goker, Erdem; Felip Font, Enriqueta; Cobo, Manuel; Lu, Shun (Elsevier, 2021-07) -
Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC
Garassino, Marina Chiara; Novello, S.; Halmos, Balazs; Felip Font, Enriqueta; Speranza, Giovanna; Gadgeel, Shirish (Elsevier, 2023-01) -
Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial
Peters, S.; Dziadziuszko, Rafal; Morabito, Alessandro; Felip Font, Enriqueta; Cheema, Parneet; Gadgeel, Shirish (Springer Nature, 2022-09) -
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
Andric, Zoran; Galffy, Gabriella; Szima, Barna; Stojanovic, Goran; Petrovic, Marina; Felip Font, Enriqueta; Cobo, Manuel (Elsevier, 2023-02) -
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
Tan, Benjamin; Khattak, Adnan; Felip Font, Enriqueta; Kelly, Karen; Rich, Patricia; Wang, Ding (Springer, 2021-07) -
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
Shaw, Alice Tsang; Johnson, Melissa L.; Navarro Mendivil, Alejandro; Gainor, Justin F.; Thurm, Holger; Felip Font, Enriqueta; Bauer, Todd (Springer, 2020-02) -
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta; Kim, Hye Ryun (Elsevier, 2021-12-01) -
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
Felip Font, Enriqueta; de Braud, Filippo G.; Maur, Michela; Loong, Herbert H.; Shaw, Alice Tsang; Vansteenkiste, Johan F. (Elsevier, 2020-03) -
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations
Felip Font, Enriqueta; Ardizzoni, Andrea; Ciuleanu, Tudor; Laktionov, Konstantin; Szilasi, Maria; Cobo, Manuel (Elsevier, 2020-03-01) -
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Lazar, Vladimir; Raynaud, Jacques; Magidi, Shai; Bresson, Catherine; Martini, Jean-François; Galbraith, Susan; Felip Font, Enriqueta (SAGE Publications, 2022-10-28) -
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section
Sánchez Martínez, Domingo Antonio; Quilez‑Cutillas, Aliica; Jiménez Labaig, Pablo; Sesma, Andrea; Tarazona, Noelia; Pacheco-Barcia, V.; Felip Font, Enriqueta; Elez Fernandez, Mª Elena (Springer, 2023-03) -
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Lazar, Vladimir; Magidi, Shai; Girard, Nicolas; Savignoni, Alexia; Martini, Jean-François; Massimini, Giorgio; Braña Garcia, Irene; Tabernero Caturla, Josep; Felip Font, Enriqueta (Nature Research, 2021-04-28) -
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
Valencia, Karmele; Echepare, Mirari; Teijeira, Alvaro; Pasquier, Andrea; Bértolo, Cristina; Sainz Zubieta, María Cristina; Felip Font, Enriqueta (Rockefeller University Press, 2022-12-05) -
Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
Riveiro Barciela, Maria del Mar; Felip Font, Enriqueta; Suarez-Almazor, Maria (Frontiers Media, 2023-01-05) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo Castañeda, David; Rezqallah Aron, Maria Alejandra; Amat, Ramon; Pedrola Gómez, Anna; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan; Dienstmann, Rodrigo (Nature Research, 2021-11-01) -
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design
Riely, Gregory; Ahn, Myung-Ju; Felip Font, Enriqueta; Ramalingam, Suresh; Tsao, Anne; Smit, Egbert (Future Medicine, 2022-03) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin Benzaquen, Ana Mazaltob; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Ramos Masdeu, Laia; Saura Manich, Cristina; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2020-05-14) -
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Nishio, Makoto; Felip Font, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming (Elsevier, 2020-04)